Iconovo: Progress in intranasal GLP-1 development - Redeye
Redeye is positive about Iconovo’s progress in the GLP-1 space and notes that the development timeline appears to be on track. We look forward to upcoming updates and will continue to closely follow the programme as it advances.
ANNONS
Redeye is positive about Iconovo’s progress in the GLP-1 space and notes that the development timeline appears to be on track. We look forward to upcoming updates and will continue to closely follow the programme as it advances.